The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.
Launched by BISPEBJERG HOSPITAL · Mar 6, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Normal health confirmed through; Interview and Medical examination
- • Normal values with respect to blood concentrations of fasting plasma glucose, fasting plasma total cholesterol, fasting triglycerides, HDL, LDL, creatinine, liver function tests, and electrolytes
- • Informed consent
- Exclusion Criteria:
- • Immunosuppressive treatment in the previous 12 months
- • Alcohol abuse
- • Medical treatment with oral glucocorticoids, dipeptidyl peptidase-4 (DPP-4) inhibitors, or GLP-1 receptor agonists, which, in the opinion of the principal investigator, may interfere with glucose metabolism
- • Use of lithium
- • Medical treatment that affects insulin secretion or the renin-angiotensin-aldosterone system
- • Liver disease (ALT \> 2x normal value)
- • Renal impairment (serum creatinine \> 130 µM and/or albuminuria)
- • Individuals with severe claustrophobia
- • Individuals with MR-incompatible foreign bodies
- • Individuals with hypertension
About Bispebjerg Hospital
Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
